Stage IVB Pancreatic Cancer Recruiting Phase 1 Trials for DB09037 (Pembrolizumab)

IndicationStatusPhase
DBCOND0029409 (Stage IVB Pancreatic Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03095781Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerTreatment